GlobalData on MSN6 天
Lineage begins study of OPC1 delivering device for spinal cord injury treatment
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.3cY8rBmp.js ...
Yahoo Finance5 天
Lineage Cell Therapeutics, Inc. (LCTX)
After hours: February 14 at 7:45:57 PM EST Loading Chart for LCTX ...
Lineage Cell Therapeutics’ (LCTX) Buy Rating Reaffirmed at HC Wainwright
HC Wainwright reissued their buy rating on shares of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX – Free Report) in a report released on Tuesday morning,Benzinga reports. The firm currently has a ...
Pharmabiz5 天
Lineage Cell Therapeutics initiates DOSED clinical study of OPC1 for spinal cord injury
Lineage Cell Therapeutics initiates DOSED clinical study of OPC1 for spinal cord injury: Carlsbad, California Thursday, February 13, 2025, 14:00 Hrs [IST] Lineage Cell Therapeutic ...
The Secret to Healthy Aging? Scientists Uncover the Power of Selenoproteins
A research team from Osaka University investigates the impact of antioxidant enzymes on specific cell types and their role in ...
PipelineReview.com6 天
Lineage Initiates Clinical Study of OPC1 for Spinal Cord Injury
Safety Study of Stem Cell-derived Transplant Includes Subacute and Chronic SCI Patients. CARLSBAD, CA, USA I 11, 2025 I Lineage Cell Therapeutics, Inc. (NYSE American and ...
美股内部交易 | Lineage Cell于2月12日披露2笔公司内部人交易情况
2025年2月12日， Lineage Cell（LCTX）披露2笔公司内部人交易情况。董事Culley Brian M于2025年2月11日卖出1.25万股。 【公司资料】 Lineage Cell Therapeutics, Inc.于1990年在加利福尼亚州成立。该公司是一家临床阶段的生物技术公司，开发新型同种异体或“现成的”细胞疗法，以满足未满足的医疗需求。公司项目基于公司专有的基于细胞的 ...
Yahoo Finance5 天
Lineage Cell Therapeutics, Inc. (LCTX)
After hours: 7:45:57 p.m. EST ...
gut.bmj2 天
Reparative immunological consequences of stem cell transplantation as a cellular therapy ...
Background Treatment strategies for Crohn’s disease (CD) suppress diverse inflammatory pathways but many patients remain ...